Xylazine — Medical and Public Health Imperatives-Reference-Cited by-同舟云学术

Xylazine — Medical and Public Health Imperatives

Published:2023-06-15 Issue:24 Volume:388 Page:2209-2212
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Gupta Rahul¹,Holtgrave David R.¹,Ashburn Michael A.¹

Affiliation:

1. From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2303120

Reference4 articles.

1. Xylazine and Overdoses: Trends, Concerns, and Recommendations

2. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework

3. Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl/xylazine;The American Journal of Emergency Medicine;2024-11

2. Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000–2021;Drug and Alcohol Dependence;2024-10

3. Xylazine Adulteration in Illicit Fentanyl: A Threat to Public Health;Journal of Pharmacy Practice;2024-09-05

4. Fentanyl and xylazine on the Northern Border of Mexico: A New Challenge for Drug Health Policy;Salud mental;2024-09-01

5. Overdoses with Xylazine and Fentanyl Recorded in Pennsylvania’s Overdose Information Network;2024-08-30